Isaac Francis

Cross River has partnered with X Money to provide embedded banking services for peer-to-peer payments on X.

Bitmine Immersion Technologies bought nearly 10,000 Ether (CRYPTO:ETH) over the past week, increasing its holdings to 5.79 million ETH, or about 4.8% of the cryptocurrency's total supply.

IGO (ASX:IGO) increased its net cash position to $386.5 million as higher realised spodumene prices boosted fourth-quarter earnings.

MapLight Therapeutics NASDAQ:MPLT) reported positive topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA in adults with acute exacerbation of schizophrenia.

Diana (NYSE:DSX) terminated its tender offer for Genco (NYSE:GNK) to force negotiations regarding its $27.34 per share acquisition proposal.

Luxfer Holdings (NYSE:LXFR) has entered into a definitive agreement to be acquired by affiliates of Wynnchurch Capital in an all-cash transaction that will pay shareholders $17.37 per ordinary share.

Gossamer Bio (NASDAQ:GOSS) has announced a series of strategic and regulatory updates, highlighted by plans to submit a New Drug Application (NDA) for its lead candidate, seralutinib, in September 2026.

Legend Biotech (NASDAQ:LEGN) announced a significant leadership transition, confirming that Ying Huang, Ph.D., has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors, effective July 24, 2026.

Japanese regulators are considering increasing the leverage limits available for cryptocurrency trading as part of a broader review of the country's digital asset rules.

argenx (NASDAQ:ARGX) agreed to acquire Forte Biosciences (NASDAQ:FBRX) for $77 per share, valuing the company at $2.2 billion.